The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  AspenBio Pharma Inc. (APPY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Virtual Investing at UpDown and MarketGuru

Jan 02, 2009 04:21 PM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

Virtual Investing at UpDown and MarketGuru

The accompanying table includes the stocks in my MarketGuru virtual portfolio under MikeHavRx , which I began about one week ago.

Below is my current UpDown virtual investing portfolio, which is positioned to add some more offensive stock picks such as CME and Apple since it looks like the market rally is gaining momentum. Click on any of the company names below for a link to all of my articles.

Start earning real money with zero risk while improving your trading skills and strategies at the UpDown Virtual Investing website -- just click on any of the text links to the site in this article to sign up today.

Altria (MO)

Apple (AAPL)

AspenBio Pharma (APPY)

China Medical (CMED)

CME Group (CME)

Cypress Bioscience (CYPB)

UpDown is the ultimate risk/reward trade since it is free and easy to register and users can earn real money at the site in two ways. The first is by beating the market (S&P 500 Index) on a monthly basis and the second is by referring investors. However, the referral system is designed to encourage legitimate referrals by basing the payment on how much the referred person earns on the site. So, if you refer someone who earns $100, you will receive 10% or $10 as a referral bonus.

The UpDown is also a social networking site for investors, allowing users to form groups, post stock ideas, and collaborate with other investors. The UpDown allows users to trade frequently and closely resembles real-world trading conditions by placing restrictions on maximum positions based on average trading volume and no position may exceed 20% of a user's portfolio value.


APPY:  This call was made on 01/02/09 @ $6.392
Rating:   Positive   $6.392 (01/02/09)
Closed:   01/10/2009 @ $6.44 (+0.75% in 8 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +35.25% 368
2 18.14 +70.90% 206
3 17.66 +25.78% 53
4 13.47 +14.32% 60
5 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
AspenBio Pharma Inc. (APPY)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
80.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
EXAS Positive -0.76% 11/07/09
NFES N/A Positive n/a 11/07/09
IMUC N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09
PFE Negative -0.53% 11/04/09

View All >
   
Mike Havrilla previously rated APPY
Positive -28.69% Extreme FDA Medical Device Trades: 7 Stocks Under $5
07/05/2009
9
Positive +29.51% Updated Clinical Trial and FDA Decision Calendars
03/15/2009
9
Positive -77.17% 20 Emerging Healthcare Stocks to Watch in '09
01/10/2009
9
Positive +0.00% Buyout Binge Begins for Bio-Pharma, Diagnostics
01/10/2009
9
Positive +3.60% My UpDown Virtual Investing Portfolio
01/01/2009
9
Positive +1.98% Four Healthy Stocks Trading Above Moving Averages
12/31/2008
9
Positive -0.82% Anticipating Active '09 for AspenBio Pharma
12/31/2008
9
Positive +5.35% Top Five Rated Preventive Medicine Stocks
12/29/2008
9
Positive -6.31% A New Emerging Diagnostics Index
12/26/2008
9
Positive +11.96% Five Healthcare Stocks for a Happy New Year
12/23/2008
9
Positive +10.40% Stock Picks for a 'Roadhouse Blues' Market
11/21/2008
9
Positive +2.04% Six Healthcare Stocks on Sale
10/24/2008
9
Positive +8.89% Market Notes: AspenBio Pharma + Microsoft-Yahoo!?
10/16/2008
9
Positive -27.54% An Overview of the Global Animal Care Industry
08/15/2008
3
Positive +2.64% AspenBio Pharma Executes On Its Plan for FDA Clearance of AppyScore
07/19/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch